Joel I. Papernik
Create Word Document
Joel is a corporate and mergers and acquisitions attorney who is esteemed for his work on life sciences deals. He leads acquisitions of public and private companies across a wide range of industries and assists all types of companies with the intricate processes of offloading enterprises, divisions, and subsidiaries. His capabilities include managing collaborative arrangements, licensing transactions, and other strategic deals for life sciences companies and helping overseas firms set up operations and make acquisitions in the United States. He also serves as counsel to boards of directors and special committees.
Joel concentrates on corporate, commercial, securities, corporate governance, and mergers and acquisitions matters as well as strategic transactions and corporate structuring. He is a member of the firm's Opinions Committee and has also served as a member of the firm's Policy Committee.
He has extensive experience counseling high-technology businesses and the individuals creating them. He frequently guides acquisitions, collaborations, and licensing transactions in the life sciences industry. He frequently counsels boards of directors and their committees.
Joel has also functioned as counsel for several publicly and privately held companies in various industries, including media, software, packaged and consumer goods, apparel, financial, packaging, and real estate. In addition to guiding numerous domestic mergers, acquisitions, dispositions, and public offerings to successful conclusions, he has served as US counsel to several overseas firms in connection with establishing operations, their conduct of public offerings, and their acquisitions in the United States.
In the mergers and acquisitions area, Joel has led the acquisitions of public and private companies in media, marketing, apparel, life sciences, medical device, and other industries, and has represented numerous public and private sellers of entire enterprises, divisions, or subsidiaries. He has also been involved in acquiring businesses in Chapter 11 proceedings and has directed several corporate reorganizations.
He has served as counsel to many boards of directors and special committees, and advised investment bankers on a myriad of matters, including representing them in their roles as financial advisors and managing underwriters.
Joel is a frequent lecturer on topics such as underwriting public offerings of securities, corporate compliance, financings, acquiring and selling firms, fairness opinions, biotech-to-biotech acquisitions and dispositions, private placements, and legal opinion matters.
Columbia University (JD)
Yale University (BA)
New York Super Lawyers: Mergers & Acquisitions (2006 – 2019)
Best Lawyers in America: Corporate Law (1993 – 2021)
Martindale-Hubbell AV Preeminent
Program Committee, 2015 Biotechnology International Organization (BIO) Convention
Past chair, Corporation Law Committee of the Association of the Bar of the City of New York
Member, Securities Law Committee of the New York State Bar Association
Member, TriBar Opinion Committee
Member, Negotiated Acquisitions Committee of the American Bar Association
Board Member, New York Biotechnology Association (NYBA)
MedTech, Tools, and Devices
Activism: An Overview from the Company Perspective
September 26, 2014 |Advisory
One Hundred Ten Mintz Attorneys Ranked as Leaders by Best Lawyers 2021
Twenty-Four Mintz Attorneys Named 2019 New York Super Lawyers and Rising Stars
One Hundred Mintz Attorneys Ranked as Leaders by Best Lawyers 2020
2016 NewYorkBIO Annual Conference
2015 BIO International Convention
NewYorkBIO 25th Anniversary Conference
September 26, 2014 | Advisory | By Joel Papernik
Increasingly, companies are being confronted with shareholders seeking to exercise power and influence over business activities. The term "activism" has become a buzzword to refer to shareholders seeking to make operational, governance, and structural changes in the companies in which they own a stake.
Eighty-Nine Mintz Attorneys Included in the Best Lawyers in America, 2019 Edition
Eighty-Five Mintz Attorneys Included in the Best Lawyers in America, 2018 Edition
Best Lawyers named 85 Mintz attorneys to its 2018 list of The Best Lawyers in America. In addition, Mintz attorneys Matthew J. Gardella and Samuel M. Tony Starr were named "Lawyer of the Year" in their respective practice areas.
Twenty-Eight Mintz Attorneys Named 2016 New York Super Lawyers and Rising Stars
Sixteen Mintz attorneys have been named New York Super Lawyers for 2016 and twelve have been named New York Rising Stars. The list will be published in a special advertising supplement in The New York Times Magazine and in a stand-alone magazine, New York Super Lawyers - Metro Edition.
Seventy-Three Mintz Attorneys Included in The Best Lawyers in America, 2017 Edition
Best Lawyers named 73 Mintz attorneys to its 2017 list of The Best Lawyers in America. Mintz attorneys selected for inclusion in this year's list span 44 practice areas.
Twenty-Three Mintz Attorneys Named 2015 New York Super Lawyers and Rising Stars
Seventy-One Mintz Attorneys Included in The Best Lawyers in America, 2016 Edition
Mintz's Joel Papernik to Moderate Panel on Shareholder Activism at 2015 BIO International Convention
Mintz's Joel Papernik to Present on Shareholder Activism at New York BIO 25th Anniversary Conference
Thirteen attorneys from Mintz have been named New York Super Lawyers for 2014 and eleven have been named New York Rising Stars. The list will be published in a special advertising supplement in The New York Times Magazine and in a stand-alone magazine, New York Super Lawyers - Metro Edition.
Sixty-Two Mintz Attorneys Included in The Best Lawyers in America, 2015 Edition
Mintz's Joel Papernik to Chair Panel at New York Biotechnology Association Annual Meeting
Preparing for and Addressing Activist Shareholders: The Valeant/Pershing Square Bid for Allergan
The Association of Corporate Counsel's Northeast Chapter